TCL Archive Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.” September 30, 2005
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall September 15, 1978